Real-world treatment preferences among health care providers in the United States in selecting disease modifying therapies for patients with multiple sclerosis: a discrete choice experiment

Multiple sclerosis: Diagnosis, disease-modifying therapy and prognosis

(2022) Brett S Travers et al.   Australian Journal of General Practice

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

(2022) Lawrence Steinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patient and neurologist preferences in the UK for relapsing–remitting multiple sclerosis treatments: findings from a discrete choice experiment

(2021) Tom Tencer et al.   CURRENT MEDICAL RESEARCH AND OPINION

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment

(2021) Jinender Kumar et al.   Patient Preference and Adherence

Application of Discrete Choice Experiment in Health Care: A Bibliometric Analysis

(2021) Yue Wang et al.   Frontiers in Public Health

Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options

(2020) Marcel F. Jonker et al.   MEDICAL DECISION MAKING

The prevalence of MS in the United States

(2019) Mitchell T. Wallin et al.   NEUROLOGY

The long-term effects of disease modifying therapies on disability in people living with multiple sclerosis: A systematic review and meta-analysis

(2019) Suzi B. Claflin et al.   Multiple Sclerosis and Related Disorders

Multiple sclerosis - a review

(2018) R. Dobson et al.   EUROPEAN JOURNAL OF NEUROLOGY

Treatment burden should be included in clinical practice guidelines

(2018) Claudia C Dobler et al.   BMJ-British Medical Journal

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study

(2017) Hanne Marie Bøe Lunde et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Perceptual decisions are biased by the cost to act

(2017) Nobuhiro Hagura et al.   eLife

Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis

(2017) Ana L. Hincapie et al.   Journal of Managed Care & Specialty Pharmacy

Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force

(2016) A. Brett Hauber et al.   VALUE IN HEALTH

Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment

(2016) Eva Martinez et al.   Patient Preference and Adherence

Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases

(2016) Daniele D’Ambrosio et al.   Therapeutic Advances in Chronic Disease

Disease-modifying treatments for multiple sclerosis - a review of approved medications

(2015) Ø. Torkildsen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey

(2015) CA Mansfield et al.   VALUE IN HEALTH

Administrative Work Consumes One-Sixth of U.S. Physicians' Working Hours and Lowers their Career Satisfaction

(2014) Steffie Woolhandler et al.   INTERNATIONAL JOURNAL OF HEALTH SERVICES

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sex and gender issues in multiple sclerosis

(2013) Hanne F. Harbo et al.   Therapeutic Advances in Neurological Disorders

Physician Burnout

(2011) Liselotte N. Dyrbye et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

(2011) John F.P. Bridges et al.   VALUE IN HEALTH

Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice

(2010) FM Hajjaj et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

(2008) N Grytten Torkildsen et al.   Multiple Sclerosis Journal